from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2396/PE_PGRS41

LFCtreatmentdescriptionclass of inhibitor

1.959

Amikacinug/mL Amikacintranslation

2.712

Cap5-10ug/mL Capreomycintranslation

4.713

Rox10-50 ug/mL Roxithromycintranslation

-0.246

SM2-5 ug/mL Streptomycintranslation

3.038

Tet5-10 ug/mL Tetracyclinetranslation

0.381

Rif0.2-5ug/mL Rifampicintranscription

0.024

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.692

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.832

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.476

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.331

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.670

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.608

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.942

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.119

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.704

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.428

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.471

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.827

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.573

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.388

KCN5-20 ug/mL Potassium cyaniderespiration

-0.809

NaN30.2-2 mM Sodium aziderespiration

1.983

Nigericin50 uM Nigericinrespiration

-0.440

TRC10-150 ug/mL Triclosanrespiration

-0.453

TRZ10-25 ug/mL Thioridazinerespiration

-0.183

Valinomycin0.5-10 uM Valinomycinrespiration

-0.624

ZnSO42 mM ZnSO4respiration

-0.164

menadione6-10 ug/mL Menadionerespiration

-0.441

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.520

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.414

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.783

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.038

NRP_1Non-replicating persistence stage 1dosRassociated

0.031

Amp0.2mg/mL AmpicillincellWall

-0.708

Cephalexin20-100 ug/mL CephalexincellWall

-0.283

Cerulenin0.32-5 ug/mL CerulenincellWall

0.447

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.339

EMB10-20 ug/mL EthambutolcellWall

-0.261

Eta12-40 ug/mL EthionamidecellWall

-0.256

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.180

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.350

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.711

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.534

BZA0.12 mg/mL BenzamidearomaticAmides

0.311

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.208

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.331

H2O24 mM hydrogen peroxideDNAdamaging

-0.468

Levo10 ug/mL LevofloxacinDNAdamaging

0.181

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.132

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.276

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.196

UVUV-irradiationDNAdamaging

-0.299

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.641

Antimycin12.5-50 ug/mL Antimycin A?

-0.715

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.719

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.479

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.151

PA8240.2-2 ug/mL PA-824?

-0.466

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.177

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.591

Verapamil50 uM Verapamil?

0.236

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.498

methoxatin10-20 ug/mL Methoxatin?